Atherosclerosis (also known as arteriosclerotic vascular disease or ASVD) is a condition in which an artery wall thickens as the result of a build-up of fatty materials such as cholesterol.
"Screening asymptomatic individuals for subclinical atherosclerosis has the potential to improve cardiovascular disease prevention strategies, but any screening program must yet be proven to prevent actual cardiovascular disease, an editorial viewpoint and commentary suggest."
In the Journal of the American College of Cardiology, Prediman Shah (Cedars-Sinai Medical Center, Los Angeles, California) explains that screening is central to the primary prevention of CVD.
In a related commentary, Michael Lauer (National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA) argues that undertaking such screening has disadvantages, such as over diagnosis, which are often overlooked.
So, what do we conclude?
Also see- Number needed to screen: development of a statistic for disease screening
Also see- Number needed to screen: development of a statistic for disease screening
No comments:
Post a Comment